Watching your hair thin and wondering if there's a drug-free, surgery-free option? Low-Level Laser Therapy (LLLT) is an FDA-cleared, non-invasive treatment that uses safe, low-power red light to energise hair follicles at the cellular level, stimulating growth, reducing shedding, and thickening existing hair. No pain, no downtime, no drugs.
LLLT uses low-power red light, typically at wavelengths of 630–680 nm to penetrate the scalp and reach hair follicles directly. This wavelength range lies within the 'optical window' of biological tissue, meaning it passes safely through the skin and reaches the cells that matter.The process is called photobiomodulation, a clinically established term for using light to trigger beneficial changes in living cells. In simple terms, the red light acts like a battery charger for your hair follicle cells. It stimulates the mitochondria (the energy centre of each cell) to produce more ATP, the fuel that powers cellular activity. This leads to improved blood circulation in the scalp, activation of dormant follicles, prolonged growth phase of hair, and reduced shedding.
Your scalp and hair loss pattern are assessed using clinical tools to evaluate the extent and type of hair loss and determine the most suitable treatment plan.
The LLLT helmet is positioned securely on your head to ensure calibrated red light is delivered evenly across the entire treatment area no gaps in coverage.
Each session runs for 20 minutes. Sessions are conducted 3 times per week on non-consecutive days for optimal follicle stimulation without over-exposure.
No downtime is required. You can resume all normal activities immediately. Your doctor will advise on complementary treatments such as Minoxidil, PRP, or nutritional support to further enhance results.
Deliver advanced LLLT using FDA-approved, medical-grade technology calibrated to clinical standards rather than consumer-grade devices.
Assess your scalp and hair loss pattern before each course of treatment to ensure the protocol is matched to your specific condition.
Stimulate follicles through targeted red light and photobiomodulation the same mechanism validated across multiple randomised controlled trials.
Customise the treatment plan to your hair loss type and stage, and integrate LLLT with complementary treatments where appropriate.
Provide comprehensive aftercare support and follow-up to track your progress over time.
LLLT is suitable for patients who meet any of the following criteria:
Experiencing early-to-moderate hair loss or thinning (Norwood-Hamilton Grades 1–4 for men; Ludwig Grades 1–2 for women).
Diagnosed with androgenetic alopecia (male or female pattern hair loss) the condition with the strongest clinical evidence for LLLT.
Experiencing unexplained hair shedding of more than 100 strands per day, especially following illness, rapid weight loss, or significant life stress (telogen effluvium).
Needing enhancement of transplanted hair growth, LLLT supports faster healing and improved graft survival post-transplant.
Having hair thinning related to PCOS or post-partum hormonal changes.
Seeking a drug-free, non-invasive alternative or complement to existing medical treatments.
A personalised consultation with our doctor will determine whether LLLT is the right option for you.
Red light begins energising follicle cells and improving scalp circulation. You may not see a visible change yet, but the biological process has started.
Reduced hair shedding as low-level laser therapy activates dormant follicles and extends the growth phase. Many patients notice less hair on the brush or in the shower.
Hair becoming noticeably denser and thicker with consistent use. This is when most patients first see a clearly visible improvement.
Fuller, stronger hair with ongoing treatments. Hair density continues to improve. Most randomised clinical trials report their primary results at this stage.
Some patients experience a brief increase in shedding in the early weeks. This is normal, new hairs growing in push out older, weaker strands. It is a positive sign, not a setback.
Ongoing sessions, typically 3 times per week, are needed to maintain results. Hair growth cycles require consistent stimulation to sustain the improvements achieved.
LLLT is a non-invasive, FDA-cleared treatment that uses safe, low-power red light at 630–680 nm wavelengths to stimulate hair follicles. This process, called photobiomodulation, works by energising the mitochondria (energy centres) inside follicle cells, boosting ATP production, improving scalp blood flow, and shifting dormant follicles into the active growth phase. It is painless, drug-free, and requires no downtime.
Yes. Multiple randomised controlled trials have demonstrated that LLLT produces statistically significant improvements in hair density for both men and women with androgenetic alopecia (pattern hair loss). The strongest evidence is for early-to-moderate hair loss. One study also found that LLLT and Minoxidil were similarly effective, and that combining them was even more effective than either alone.
At Kibo Clinics, sessions are conducted 3 times per week on non-consecutive days, for 20 minutes per session. This protocol is consistent with the evidence from published clinical trials on helmet-type LLLT devices. Your doctor will confirm the schedule most appropriate for your specific condition.
LLLT is one of the safest treatments available for hair loss. Side effects are rare. Some users experience mild scalp warmth or temporary tingling during a session. A small number notice brief increased shedding in the early weeks. This is a normal part of the process as new hair pushes out older strands. Serious side effects are extremely rare when an FDA-cleared, medical-grade device is used under professional supervision.
Most patients begin to notice results after 3–4 months of consistent use typically reduced shedding first, followed by visible thickening. Because hair grows in cycles, ongoing treatment is important. The most significant improvements are generally seen between months 6 and 12. Stopping treatment early may allow hair loss to resume.
Yes, and clinical evidence suggests the combination is more effective than either treatment alone. A randomised controlled trial found that patients using both LLLT and Minoxidil had significantly greater increases in hair density than those using either therapy alone. LLLT also supports post-transplant healing and graft survival. Your doctor will advise the most effective combination for your condition.
At-home laser helmets vary widely in quality, diode count, and calibration. In-clinic LLLT at Kibo uses FDA-approved, medical-grade devices with clinically calibrated output administered alongside a scalp assessment and personalised treatment protocol. The key difference is precision, professional oversight, and integration with a broader hair restoration plan not just the device itself.
Many at-home devices use the same wavelength range and are clinically tested. However, without a professional scalp assessment, calibrated dosing, and integration with a broader treatment plan, at-home use is less precise. For mild maintenance, at-home devices may be appropriate. For moderate hair loss or as part of a restoration plan, in-clinic treatment with professional supervision delivers more consistent results.
LLLT works best for individuals with early-to-moderate androgenetic alopecia (male or female pattern hair loss Norwood Grades 1–4 or Ludwig Grades 1–2). It is also effective for telogen effluvium (stress or hormonal shedding) and post-transplant support. It is less suited for very advanced hair loss where follicles have been permanently lost, or for scarring alopecia conditions.
Book a free consultation with our experienced doctors to discover your best options and gain clear insight into your expected results.
YOUR HAIR JOURNEY STARTS HERE
